Citable company snapshot
Lilly (Eli)'s latest SEC-sourced 2026-03-31 period shows $19.80B in revenue and $7.40B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $19.80B | $19.29B | +2.6% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $7.40B | $6.64B | +11.4% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $5.33B | $3.22B | +65.4% |
| Free Cash Flow (computed) | Sep 30, 2022 | $1.60B | $812.30M | +96.9% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 30, 2026; accession 0000059478-26-000045.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
